Detailansicht

Wissensnetz

Person

Boris Hadaschik (1974-)

Urologe

Name	Boris Hadaschik
Zeit	1974- (Lebensdaten)
Ort	Deutschland
Akademischer Grad bzw. Titel	Prof. Dr.
Beruf	Urologe (charakteristischer Beruf)
Variante	Boris Alexander Hadaschik B. Hadaschik Boris A. Hadaschik B. A. Hadaschik
Beziehung	Chirurgische Universitätsklinik (Heidelberg) (10/2008-07/2020) Urologische Klinik und Poliklinik (Essen) (Direktor) (seit 03/2017)
Weitere Angaben	Diss. Medizinische Fakultät; Oberarzt an der Urologischen Klinik, Universitätsklinikum Heidelberg
Datensatztyp	Person
GND-Nummer	124300553
Datensatz-ID	124300553
Beteiligt an alle anzeigen Apalutamid/ADT im mHSPC : starke Wirksamkeit in Zulassungsstudie und Daten aus dem Alltag Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals Proteasomal processing immune escape mechanisms in platinum-treated advanced bladder cancer Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals M0CRPC overview of management options Correlation between genomic index lesions and mpMRI and 68Ga-PSMA-PET/CT imaging features in primary prostate cancer Genomic features of renal cell carcinoma with venous tumor thrombus 68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer Incidental appendectomy during robotic laparoscopic prostatectomy—safe and worth to perform? Fokale Therapie des Prostatakarzinoms Ureterocystoneostomy in complex oncological cases with an “Uebelhoer” modified Boari bladder flap Quality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancer Bedeutung und Nutzen von PSMA-Liganden beim Prostatakarzinom Effective downsizing but enhanced intratumoral heterogeneity following neoadjuvant sorafenib in patients with non-metastatic renal cell carcinoma Stellenwert der PSMA-Liganden-Bildgebung beim Prostatakarzinom Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients MRT/TRUS-fusionierte Biopsiesysteme : Stellenwert bei der fokalen Therapie des Prostatakarzinoms Rezidivfreies Überleben nach radikaler Prostatektomie und PDE-5-Hemmer-Einnahme Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinoma Wertigkeit der multiparametrischen MRT und der MRT-TRUS-Fusionsbiopsie bei primär negativ biopsierten Patienten Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stage Selbstbild und erektile Dysfunktion 45-jähriger Männer : Ergebnisse eines Begleitprojekts der PROBASE-Studie Fokale Therapie von kleinen Nierentumoren : Beobachtung, Ablation oder Operation Follow-up after focal therapy in renal masses: an international multidisciplinary Delphi consensus project 68Ga-PSMA-11 dynamic PET/CT imaging in biochemical relapse of prostate cancer Primary melanoma of the prostate: case report and review of the literature Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity Stellenwert der MRT/TRUS-Fusionsbiopsie im Rahmen der Primärbiopsie beim Prostatakarzinom Primary melanoma of the prostate: case report and review of the literature Irreversible Elektroporation : Aktueller Stellenwert in der fokalen Therapie des Prostatakarzinoms The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer Current state of the art, multimodality research and future visions for the treatment of patients with prostate cancer: consensus results from "Challenges and Chances in Prostate Cancer Research Meeting 2013" Fokale Therapie des Prostatakarzinoms in Deutschland – Status 2014 Ion Prostate Irradiation (IPI) – a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker Untersuchungen zur Rolle der C282Y-Mutation des Hämochromatoseproteins HFE bei der Regulation des zellulären Eisenhaushalts

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Boris Hadaschik (1974-)

Apalutamid/ADT im mHSPC : starke Wirksamkeit in Zulassungsstudie und Daten aus dem Alltag

Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study

Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals

Proteasomal processing immune escape mechanisms in platinum-treated advanced bladder cancer

Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals

M0CRPC overview of management options

Correlation between genomic index lesions and mpMRI and 68Ga-PSMA-PET/CT imaging features in primary prostate cancer

Genomic features of renal cell carcinoma with venous tumor thrombus

68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer

Incidental appendectomy during robotic laparoscopic prostatectomy—safe and worth to perform?

Fokale Therapie des Prostatakarzinoms

Ureterocystoneostomy in complex oncological cases with an “Uebelhoer” modified Boari bladder flap

Quality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancer

Bedeutung und Nutzen von PSMA-Liganden beim Prostatakarzinom

Effective downsizing but enhanced intratumoral heterogeneity following neoadjuvant sorafenib in patients with non-metastatic renal cell carcinoma

Stellenwert der PSMA-Liganden-Bildgebung beim Prostatakarzinom

Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI

Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database

F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients

MRT/TRUS-fusionierte Biopsiesysteme : Stellenwert bei der fokalen Therapie des Prostatakarzinoms

Rezidivfreies Überleben nach radikaler Prostatektomie und PDE-5-Hemmer-Einnahme

Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinoma

Wertigkeit der multiparametrischen MRT und der MRT-TRUS-Fusionsbiopsie bei primär negativ biopsierten Patienten

Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stage

Selbstbild und erektile Dysfunktion 45-jähriger Männer : Ergebnisse eines Begleitprojekts der PROBASE-Studie

Fokale Therapie von kleinen Nierentumoren : Beobachtung, Ablation oder Operation

Follow-up after focal therapy in renal masses: an international multidisciplinary Delphi consensus project

68Ga-PSMA-11 dynamic PET/CT imaging in biochemical relapse of prostate cancer

Primary melanoma of the prostate: case report and review of the literature

Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity

Stellenwert der MRT/TRUS-Fusionsbiopsie im Rahmen der Primärbiopsie beim Prostatakarzinom

Primary melanoma of the prostate: case report and review of the literature

Irreversible Elektroporation : Aktueller Stellenwert in der fokalen Therapie des Prostatakarzinoms

The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

Current state of the art, multimodality research and future visions for the treatment of patients with prostate cancer: consensus results from "Challenges and Chances in Prostate Cancer Research Meeting 2013"

Fokale Therapie des Prostatakarzinoms in Deutschland – Status 2014

Ion Prostate Irradiation (IPI) – a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique

Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker

Untersuchungen zur Rolle der C282Y-Mutation des Hämochromatoseproteins HFE bei der Regulation des zellulären Eisenhaushalts